Home > Insider Trading > Filing (0000921895-19-000047)

Filing Details

Accession Number:: 0000921895-19-000047
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-09 20:49:06
Reporting Period:: 2018-04-13

Accepted Time:: 2019-01-09 20:49:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727510	Enzon Pharmaceuticals Inc.	ENZN	Biological Products, (No Disgnostic Substances) (2836)	222372868

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1265094	Jonathan Couchman	630 Fifth Avenue Suite 2260 New York NY 10020	No	No	Yes	Yes
1571659	Xstelos Corp.	630 Fifth Avenue Suite 2260 New York NY 10020	No	No	Yes	Yes
1737322	Fund Family Couchman	630 Fifth Avenue, Suite 2260 New York NY 10020	No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.01 Par Value	Acquisiton	2018-04-13	4,700	$0.26	3,582,364	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-04-16	185,700	$0.26	3,768,064	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-02	3,000	$0.26	3,771,064	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-07	33,500	$0.26	3,804,564	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-15	55,000	$0.26	3,859,564	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-17	4,000	$0.26	3,863,564	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-18	20,200	$0.26	3,883,764	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-21	50,000	$0.26	3,933,764	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-05-22	5,500	$0.26	3,939,264	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-04	1,000	$0.26	3,940,264	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-05	2,000	$0.26	3,942,264	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-22	68,195	$0.26	4,010,459	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-25	500	$0.26	4,010,959	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-26	1,120	$0.26	4,012,079	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-28	32,345	$0.26	4,044,424	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-06-29	1,300	$0.26	4,045,724	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-02	600	$0.26	4,046,324	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-03	20,000	$0.26	4,066,324	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-05	21,975	$0.26	4,088,299	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-10	2,800	$0.26	4,091,099	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-11	635	$0.26	4,091,734	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-20	355	$0.26	4,092,089	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-24	11,368	$0.26	4,103,457	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-26	26,655	$0.26	4,130,112	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-27	112	$0.26	4,130,224	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-07-30	8,255	$0.26	4,138,479	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-08-06	40,316	$0.26	4,178,795	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-08-10	9,500	$0.26	4,188,295	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-08-13	384,100	$0.26	4,572,395	No	4	P	Direct
Common Stock, $0.01 Par Value	Acquisiton	2018-08-14	3,671	$0.26	4,576,066	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation") and Xstelos Corp. ("Xstelos" and, together with Mr. Couchman and the Foundation, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
Due to the Securities and Exchange Commission's electronic filing system limitation of thirty line items on Table I, this Form 4 filing is part one of two.
The price reported is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.2400 to $0.2600. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote 3.